CAP Partners LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-3,616
Closed -$205K – 133
2024
Q4
$205K Buy
+3,616
New +$202K 0.14% 129
2024
Q2
– Sell
-4,290
Closed -$233K – 129
2024
Q1
$233K Sell
4,290
-7
-0.2% -$357 0.21% 105
2023
Q4
$220K Buy
+4,297
New +$226K 0.22% 94

Other funds holding BMY

CAP Partners LLC's BMY Position: Q1 2025 in Review

CAP Partners LLC sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 3,616 shares — an estimated $205K sold.

CAP Partners LLC first reported a position in BMY in Q4 2023 and held it in 3 quarters. The position peaked at $233K in Q1 2024. 2,486 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • CAP Partners LLC reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • CAP Partners LLC sold 3,616 Bristol-Myers Squibb shares in Q1 2025, an estimated $205K.
  • CAP Partners LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 3 quarters.
  • CAP Partners LLC's Bristol-Myers Squibb position peaked at $233K in Q1 2024.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on CAP Partners LLC's 13F filing for Q1 2025, filed 8 May 2025.